Geneva Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | $68.2M | Sell |
422,799
-3,023
| -0.7% | -$488K | 1.18% | 28 |
|
2017
Q1 | $65.8M | Sell |
425,822
-130,748
| -23% | -$20.2M | 1.18% | 27 |
|
2016
Q4 | $65.3M | Sell |
556,570
-21,989
| -4% | -$2.58M | 1.27% | 20 |
|
2016
Q3 | $65.2M | Buy |
578,559
+65,199
| +13% | +$7.35M | 1.23% | 27 |
|
2016
Q2 | $47.7M | Buy |
513,360
+11,135
| +2% | +$1.03M | 0.94% | 36 |
|
2016
Q1 | $39.3M | Buy |
502,225
+4,951
| +1% | +$388K | 0.79% | 48 |
|
2015
Q4 | $36.3M | Buy |
497,274
+4,359
| +0.9% | +$318K | 0.7% | 51 |
|
2015
Q3 | $36.6M | Buy |
492,915
+12,137
| +3% | +$901K | 0.74% | 45 |
|
2015
Q2 | $30.8M | Sell |
480,778
-1,992
| -0.4% | -$128K | 0.55% | 62 |
|
2015
Q1 | $37.3M | Sell |
482,770
-5,880
| -1% | -$454K | 0.67% | 52 |
|
2014
Q4 | $36.2M | Buy |
+488,650
| New | +$36.2M | 0.67% | 58 |
|